BBH Market Vectors Biotech ETF

  • ETF
  • BBH
  • Category
  • Health & Biotech Equities
Share
Last Updated:

BBH - Profile

Vitals

Investment Themes

Alternative ETFs in the Health & Biotech Equities Category

Sign Up for Pro to Unlock Data Sign Up
Type Ticker Expense Ratio Assets Avg. Daily Vol YTD Return
Cheapest
Largest (AUM)
Most Liquid (Volume)
Top YTD Performer

Description

The Index is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded biotech companies. Companies included in the index derive most of their revenues from bio-technology, including companies engaged primarily in research and development as well as production, marketing and sales of drugs based on genetic analysis and diagnostic equipment. To be eligible for inclusion, companies must have a market capitalization exceeding $150 million, a three-month average-daily-trading volume of at least $1 million, and at least 250,000 shares traded per month.

Realtime Rating

BBH - Realtime Rating

Sign Up for Pro to Unlock Data Sign Up

Realtime Rating Summary

BBH is a passive ETF that seeks to replicate Market Vectors US Listed Biotech 25 Index. The Index is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded biotech companies. Companies included in the index derive most of their revenues from bio-technology, including companies engaged primarily in research and development as well as production, marketing and sales of drugs based on genetic analysis and diagnostic equipment. To be eligible for inclusion, companies must have a market capitalization exceeding $150 million, a three-month average-daily-trading volume of at least $1 million, and at least 250,000 shares traded per month.

The adjacent table gives investors an individual Realtime Rating for BBH on several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. The "A+ Metric Rated ETF" field, available to ETFdb Pro members, shows the ETF in the Health & Biotech Equities with the highest Metric Realtime Rating for each individual field. To view all of this data, sign up for a free 14-day trial for ETFdb Pro. To view information on how the ETFdb Realtime Ratings work, click here.

BBH Overall Realtime Rating:

A+ Overall Rated ETF:

Metric Metric Realtime Rating A+ Metric Rated ETF
Liquidity A- XLV
Expenses B+ FHLC
Performance
Volatility
Dividend
Concentration

Knowledge Center

Sector ETFs

Alternative ETFs

Vanguard Center

Emerging Market ETFs

MLP Center

BBH In-Depth Analysis

The following tables and charts contain in-depth metrics for BBH and compare it to similar peer ETFs within its ETFdb Category.

Holdings

BBH - Holdings

Filings Data as of: Apr 05, 2015
Sign Up for Pro to Unlock Data Sign Up

Concentration Analysis

This section compares how balanced and deep BBH is relative to the peer group ETFdb Category.

Number of Holdings
BBH Rank:
BBH 26
Category Low
Category High
% Assets in Top 10
BBH Rank:
BBH 72.56%
Category Low
Category High

BBH Asset Allocation

Asset Percentage
U.S. Stocks 96.59%
International Stocks 3.5%
U.S. Bonds 0.0%
International Bonds 0.0%
Preferred Stock 0.0%
Convertibles 0.0%
Cash 0.0%
Other -0.1%

BBH Sector Breakdown

Sector Percentage
Health Care 100.1%
Financial Services 0.0%
Communication Services 0.0%
Consumer Defensive 0.0%
Real Estate 0.0%
Industrials 0.0%
Consumer Cyclical 0.0%
Basic Materials 0.0%
Energy 0.0%
Technology 0.0%
Utilities 0.0%

BBH Market Cap Breakdown

Market Cap Percentage
Giant 45.28%
Large 28.68%
Medium 23.54%
Small 2.6%
Micro 0.0%

BBH Region Breakdown

Region Percentage
U.S. 96.59%
Europe 3.5%
Middle East 0.0%
Japan 0.0%
Australia 0.0%
Africa 0.0%
Asia (Developed) 0.0%
Latin America 0.0%
Canada 0.0%
Asia (Emerging) 0.0%

BBH Market Tier Breakdown

Region Percentage
Developed 100.1%
Emerging 0.0%

BBH Country Breakdown

Country Percentage
United States 96.59%
Ireland 1.81%
Spain 1.7%
Other -0.1%
Expense

BBH - Expenses & Fees

This section compares the cost efficiency of BBH to peers in the same ETFdb Category.

Sign Up for Pro to Unlock Data Sign Up

Expenses Ratio Analysis

Expense Ratio
BBH Rank:
BBH 0.35%
Category Low
Category High

Commission Free Trading in BBH

BBH is not currently available for commission free trading on any platforms.

Category Commission Free Trading

There are 3 other ETFs in the Health & Biotech Equities ETFdb Category that are also eligible for commission free trading:

Performance

BBH - Performance

This section shows how BBH has performed relative to its peer group ETFdb Category.

Sign Up for Pro to Unlock Data Sign Up
1 Week Return
BBH Rank:
BBH -0.69%
Category Low
Category High
4 Week Return
BBH Rank:
BBH 1.21%
Category Low
Category High
13 Week Return
BBH Rank:
BBH 5.27%
Category Low
Category High
26 Week Return
BBH Rank:
BBH 11.01%
Category Low
Category High
Year to Date Return
BBH Rank:
BBH 11.82%
Category Low
Category High
1 Year Return
BBH Rank:
BBH 48.59%
Category Low
Category High
3 Year Return
BBH Rank:
BBH 182.84%
Category Low
Category High
5 Year Return
BBH Rank:
BBH 298.44%
Category Low
Category High
Charts

BBH - Charts

The following charts can be customized to display historical performance in a number of different formats, including line charts, bar charts, and candlesticks. Time periods can be adjusted to increase or decrease the period shown, ranging from five minutes to several months.

The following chart also includes the option to compare the performance of BBH relative to other ETFs and benchmarks or to include indicators such as Bollinger Bands, relative strength, and moving averages.

Valuation

BBH - Valuation

This section shows how the P/E multiple of BBH compares to the peer group ETFdb Category.

Sign Up for Pro to Unlock Data Sign Up
P/E Ratio
BBH Rank:
BBH 23.72
Category Low
Category High

As of May 04, 2015

Dividend

BBH - Dividend

This section shows how the dividend yield of BBH compares to the peer group ETFdb Category.

Sign Up for Pro to Unlock Data Sign Up
Annual Dividend Yield
BBH Rank:
BBH 0.21%
Category Low
Category High

As of May 04, 2015

Technicals

BBH - Technicals

Sign Up for Pro to Unlock Data Sign Up

BBH Volatility Analysis

This section shows how the volatility of BBH compares to the peer group ETFdb Category.

5 Day Volatility
BBH Rank:
BBH 22.51%
Category Low
Category High
20 Day Volatility
BBH Rank:
BBH 23.36%
Category Low
Category High
50 Day Volatility
BBH Rank:
BBH 22.96%
Category Low
Category High
200 Day Volatility
BBH Rank:
BBH 25.16%
Category Low
Category High
Beta
BBH Rank:
BBH -2.31
Category Low
Category High
Standard Deviation
BBH Rank:
BBH 14.28%
Category Low
Category High

BBH Technicals

  • 20 Day MA: $131.65
  • 60 Day MA: $129.71
  • MACD 15 Period: -2.68
  • MACD 100 Period: 3.46
  • Williams % Range 10 Day: 57.73
  • Williams % Range 20 Day: 57.73
  • RSI 10 Day: 44
  • RSI 20 Day: 48
  • RSI 30 Day: 50
  • Ultimate Oscillator: 39

BBH Bollinger Bands

  • Lower Bollinger (10 Day): $124.45
  • Upper Bollinger (10 Day): $137.83
  • Lower Bollinger (20 Day): $126.39
  • Upper Bollinger (20 Day): $137.12
  • Lower Bollinger (30 Day): $126.01
  • Upper Bollinger (30 Day): $136.98

BBH Support & Resistance

  • Support Level 1: $128.24
  • Support Level 2: $127.47
  • Resistance Level 1: $130.53
  • Resistance Level 2: $132.05

BBH Stochastic

  • Stochastic Oscillator %D (1 Day): 36.23
  • Stochastic Oscillator %D (5 Day): 44.18
  • Stochastic Oscillator %K (1 Day): 41.81
  • Stochastic Oscillator %K (5 Day): 39.25
Fact Sheet

BBH - Fact Sheet

Fact sheets are issued by the ETF provider and framed by ETFdb.com. Information contained within the fact sheet is not guaranteed to be timely or accurate.

2014 Morningstar, Inc. All Rights Reserved. The information contained herein: ( 1 ) is proprietary to Morningstar and/or its content providers; ( 2 ) may not be copied or distributed; and ( 3 ) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.